Pediatrix Medical Group, Inc. Reports Q3 2026 Financial Results

Pediatrix Medical Group reported third-quarter 2026 revenue of $501.4 million, above the FactSet consensus estimate of $498.2 million. Adjusted EPS was $0.72, exceeding the $0.65 estimate. The company provides physician-led neonatal, maternal-fetal and pediatric care services; the article did not report stock-price movements or other strategic changes.